Teva Exits Japanese Generics With Plan To Sell Local Business
Firm Registers Impairment Charge Of Almost $600m As Unit Is Classified As Held-For-Sale
• By David Wallace
Teva is facing an exit from its Japanese generics business • Source: Shutterstock 
